FLUCELVAX quadrivalent (ccIIV4) a phase III randomized controlled trial : immunogenicity & safety results in young children (6 through 47 months of age)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


FLUCELVAX quadrivalent (ccIIV4) a phase III randomized controlled trial : immunogenicity & safety results in young children (6 through 47 months of age)

Filetype[PDF-445.44 KB]


  • English

  • Details:

    Supporting Files

    • No Additional Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov